GRPR and neoplasm: Furthermore, data from the Cancer Genome Atlas Research Network, including mRNA from 206 human glioblastomas, found no difference in survival between patients with tumoral samples having high, compared to those with low, GRPR mRNA tumor levels (8, 166).